Assessment of drug treatment in geriatrics with the new FORTA criteria - Preliminary clinical experience

被引:15
作者
Frohnhofen, H. [1 ,2 ,3 ]
Michalek, C. [1 ,2 ]
Wehling, M. [4 ]
机构
[1] Univ Duisburg Essen, Zentrum Altersmed, Kliniken Essen Mitte, Knappschafts Krankenhaus,Akad Lehrkrankenhaus, D-45276 Essen, Germany
[2] Univ Duisburg Essen, Klin Geriatrie, Kliniken Essen Mitte, Knappschafts Krankenhaus,Akad Lehrkrankenhaus, D-45276 Essen, Germany
[3] Univ Witten Herdecke, Lehrstuhl Geriatrie, Fak Gesundheit, Dept Humanmed, Witten, Germany
[4] Heidelberg Univ, Med Fak Mannheim, Zentrum Gerontopharm, Inst Expt & Klin Pharmakol & Toxikol, D-6900 Heidelberg, Germany
关键词
polypharmacy; priorisation; FORTA; routine clinical care; geriatrics; INAPPROPRIATE MEDICATION USE; ELDERLY-PATIENTS; SCREENING TOOL; POLYPHARMACY; POPULATION; MORTALITY; QUALITY;
D O I
10.1055/s-0031-1281530
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Multimorbidity in the elderly often leads to inappropriate and harmful polypharmacy. Various approaches have been used to prioritize components of drug treatment, especially as on negative lists like the Beers list. A new approach is the FORTA assessments system (Fit fOR The Aged) in which drugs are graded as positive (A, should be given), intermediate (B or C), and negative (D should not be given). Methods: In this pilot study of 46 patients in a geriatric ward medication was assessed on admission and at discharge, using the FORTA criteria. All changes in the number of prescribed drugs, the distribution of FORTA criteria, and the number of drug interactions were recorded. Results: The use of FORTA resulted in a decrease in the total number of prescirbed drugs from 7.3 +/- 2,9 to 6.7 +/- 2,3 (p = 0.06), and an increase in positively assessed drugs (A / B) from 59 +/- 20 to 77 +/- 38% (p < 0.01), as well as a decrease in negatively assessed drugs (D) from 7 +/- 12 to 5 +/- 9% (p = 0.06). The number of drugs assessed as intermediate (C) did not change significantly. Under-treatment decreased from 65 to 39% (p < 0.01), over-treatment from 65% to 20% (p < 0.01). The number of drug interactions decreased from 79 to 54 (p < 0.01). Conclusion: This uncontrolled pilot study indicates that the FORTA criteria can be used in day-to-day clinical care: it describes the quality of changes in drug treatment in a geriatric ward in a plausible way. This study has provided basic uncontrolled data which should be validated in controlled studies comparing the quality of treatment with or without the use of the FORTA criteria. (DKRS-ID: DRKS00000531)
引用
收藏
页码:1417 / 1421
页数:5
相关论文
共 21 条
[1]   Impact of a standardized heart failure order set on mortality, readmission, and quality and costs of care [J].
Ballard, David J. ;
Ogola, Gerald ;
Fleming, Neil S. ;
Stauffer, Brett D. ;
Leonard, Bradley M. ;
Khetan, Rainer ;
Yancy, Clyde W. .
INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE, 2010, 22 (06) :437-444
[2]   START (screening tool to alert doctors to the right treatment)an evidence-based screening tool to detect prescribing omissions in elderly patients [J].
Barry, P. J. ;
Gallagher, P. ;
Ryan, C. ;
O'Mahony, D. .
AGE AND AGEING, 2007, 36 (06) :632-638
[3]   Explicit criteria for determining potentially inappropriate medication use by the elderly - An update [J].
Beers, MH .
ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (14) :1531-1536
[4]  
Borchelt M, 1995, Z GERONTOL GERIATR, V28, P420
[5]   Pharmacotherapy of elderly patients [J].
Burkhardt, H. ;
Wehling, M. ;
Gladisch, R. .
INTERNIST, 2007, 48 (11) :1220-+
[6]  
Burkhardt H, 2007, Z GERONTOL GERIATR, V40, P241, DOI 10.1007/s00391-007-0468-9
[7]  
Chapman RH, 2003, CIRCULATION, V108, P756
[8]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[9]  
Döser S, 2004, INTERNIST, V45, P1053, DOI 10.1007/s00108-004-1268-6
[10]   Updating the beers criteria for potentially inappropriate medication use in older adults - Results of a US consensus panel of experts [J].
Fick, DM ;
Cooper, JW ;
Wade, WE ;
Waller, JL ;
Maclean, JR ;
Beers, MH .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (22) :2716-2724